ARTICLE | Company News
Ziopharm, Solasia in deal for darinaparsin
March 8, 2011 1:26 AM UTC
Ziopharm Oncology Inc. (NASDAQ:ZIOP) granted Solasia Pharma K.K. (Tokyo, Japan) exclusive rights to develop and commercialize IV and oral darinaparsin in 13 Asia-Pacific territories. The IV organic ar...